Masoumeh Omidali - MSc of Biology-Genetics, Department of Genetics, Zanjan Branch, Islamic Azad University, Zanjan, Iran.
Neda Jabbara - MSc of Biology-Genetics, Department of Genetics, Zanjan Branch, Islamic Azad University, Zanjan, Iran.
Golnaz Asaadi tehrani - Assistant Professor, Molecular Genetics Ph.D, Department of Genetics, Zanjan Branch, Islamic Azad University, Zanjan, Iran.

Aberrant DNA methylation is an epigenetic event that occurs by methyltransferases. DNMT۳A and DNMT۳B are responsible for de novo methylation that plays important roles in normal development and disease. A number of reports on methylation of various genes in endometrial cancer have been published, but most of these studies focused on tumor suppressor genes. In this study, we determined the promoter methylation pattern of DNMT۳A and DNMT۳B genes; also we analyzed correlations between methylation statuses with clinicopathological parameters. ۲۸ patients and ۲۲ healthy controls were studied. Isolation of genomic DNA from FFPE and peripheral blood was performed and Methylation-Specific PCR (MSP) was applied for analysis the promoter CpG methylation status of DNMT۳A and DNMT۳Bgenes in the studied population. A significant difference was found between the study groups and the presence of promoter CpG hypermethylation status in the DNMT۳A (P=۰.۰۴) gene. Furthermore methylation status between tissue and blood samples of DNMT۳A genewas not significant (p=۰.۷۸). Our results indicated correlation between age and menopausal state with DNMT۳B promoter methylation, but there were no significant relationships between parameters such as tumor grade, type of tumor, amount of metastasis and myometrium invasion, furthermore diabetes (p = ۰.۰۱) and obesity (p = ۰.۰۲۷) were two important items in endometrial cancer incidence. In our study hypermethylation of DNMT۳A gene was found as an important event in carcinogenesis of endometrial cancer. The inactivation epigenetic of methylation regulation genes is a common occurrence in many cancers, including endometrial cancer.

Endometrial cancer, promoter hypermethylation, MSP, DNMT۳a, DNMT۳b